Department of Pathology, University of Chicago, 5841S. Maryland Ave, Chicago, IL, USA.
Mod Pathol. 2019 Oct;32(10):1508-1520. doi: 10.1038/s41379-019-0298-5. Epub 2019 Jun 11.
Atypical hyperplasia/endometrial intraepithelial neoplasia is an accepted precursor to endometrioid-type endometrial carcinoma. Mismatch repair-deficient endometrial carcinomas are also known to be a biologically and clinically distinct subset of tumors. However, the development of microsatellite instability in endometrial carcinogenesis has not yet been evaluated by novel next-generation sequencing-based methods. We examined 17 mismatch repair-deficient endometrioid endometrial carcinomas and their paired atypical hyperplasia/endometrial intraepithelial neoplasia precursors using a next-generation sequencing panel with quantitative microsatellite instability detection at 336 loci. Findings were compared to histological features, polymerase chain reaction-based microsatellite instability testing, immunohistochemical expression of mismatch repair proteins, and tumor mutational burden calculations. All 17 endometrial carcinomas and 8/17 atypical hyperplasia/endometrial intraepithelial neoplasia showed microsatellite instability by next-generation sequencing-based testing. Endometrial carcinoma specimens showed significantly more unstable microsatellite loci than paired atypical hyperplasia/endometrial intraepithelial neoplasia (mean: 40.0% vs 19.9 unstable loci, respectively). Out of nine microsatellite-stable atypical hyperplasia/endometrial intraepithelial neoplasia specimens, four showed mismatch repair loss by immunohistochemistry. All atypical hyperplasia/endometrial intraepithelial neoplasia and endometrial carcinoma specimens with microsatellite instability were also mismatch repair-deficient by immunohistochemistry. Tumor mutational burden was significantly greater in endometrial carcinoma than in paired atypical hyperplasia/endometrial intraepithelial neoplasia specimens, and tumor mutational burden was significantly correlated with percent unstable microsatellite loci. Paired atypical hyperplasia/endometrial intraepithelial neoplasia and endometrial carcinoma specimens show progressive accumulation of unstable microsatellite loci following loss of mismatch repair protein expression. Comprehensive next-generation sequencing-based testing of endometrial carcinomas offers new insights into endometrial carcinogenesis and opportunities for improved tumor surveillance, diagnosis, and management.
非典型增生/子宫内膜上皮内瘤变是子宫内膜样型子宫内膜癌的公认前体。错配修复缺陷型子宫内膜癌也被认为是一种生物学和临床上明显不同的肿瘤亚群。然而,子宫内膜癌发生中微卫星不稳定性的发展尚未通过新型下一代测序方法进行评估。我们使用下一代测序面板,对 17 例错配修复缺陷的子宫内膜样型子宫内膜癌及其配对的非典型增生/子宫内膜上皮内瘤变前体进行了检测,该面板具有定量微卫星不稳定性检测功能,可检测 336 个位点。检测结果与组织学特征、聚合酶链反应微卫星不稳定性检测、错配修复蛋白免疫组化表达以及肿瘤突变负担计算进行了比较。所有 17 例子宫内膜癌和 17 例非典型增生/子宫内膜上皮内瘤变中有 8 例通过基于下一代测序的检测显示微卫星不稳定性。子宫内膜癌标本的不稳定微卫星位点明显多于配对的非典型增生/子宫内膜上皮内瘤变(平均值:分别为 40.0%和 19.9 个不稳定位点)。在 9 例微卫星稳定的非典型增生/子宫内膜上皮内瘤变标本中,有 4 例通过免疫组化显示错配修复缺失。所有具有微卫星不稳定性的非典型增生/子宫内膜上皮内瘤变和子宫内膜癌标本的免疫组化结果也显示错配修复缺陷。子宫内膜癌的肿瘤突变负担明显高于配对的非典型增生/子宫内膜上皮内瘤变,且肿瘤突变负担与不稳定微卫星位点的百分比显著相关。非典型增生/子宫内膜上皮内瘤变和子宫内膜癌标本随着错配修复蛋白表达缺失,微卫星不稳定位点逐渐累积。子宫内膜癌的全面下一代测序检测为子宫内膜癌的发生提供了新的见解,并为改善肿瘤监测、诊断和管理提供了机会。